Related Experiment Video
Updated: Nov 18, 2025
08:42
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
3.8K
Tricuspid valve vegetation debulking using the AngioVac system.
Sripal Bangalore1, Carlos L Alviar1, Susan Vlahakis1
1Grossman School of Medicine, New York University, New York, New York.
Summary
Tricuspid valve endocarditis with recurrent septic pulmonary emboli necessitates surgery. This case highlights percutaneous vegetation extraction as a potential alternative, emphasizing the need for further research in managing complex cases.
Area of Science:
- Cardiology
- Infectious Diseases
- Interventional Cardiology
Background:
- Tricuspid valve endocarditis (TVE) poses significant risks, including recurrent septic pulmonary emboli (SPE).
- Surgical intervention is traditionally indicated for TVE with SPE.
- Management of complex TVE cases remains challenging.
Observation:
- A case of a 36-year-old male with TVE and SPE is presented.
- The patient underwent percutaneous extraction of the tricuspid valve vegetation.
- This minimally invasive approach was utilized in a complex clinical scenario.
Findings:
- Percutaneous extraction of vegetation in TVE with SPE is technically feasible.
- The procedure offers a potential alternative to open-heart surgery.
- Detailed discussion of the procedural nuances is provided.
Implications:
- This case suggests percutaneous extraction may be a viable option for select patients with TVE and SPE.
- Further clinical trials are warranted to establish the efficacy and safety of this approach.
- Evidence-based guidelines are needed for the management of these complex cardiovascular infections.
Related Concept Videos
01:25Mitral Regurgitation III: Medical Management
123
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
123
01:25Aortic Regurgitation III: Medical Management
171
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
171
01:26Mitral Stenosis III: Medical Management
109
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
109